Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation

References

• Kantarjian, HM, Smith, TL, O'Brien, S, et al. Prolonged survival in chronic myelogenous leukemia after cytogenic response to interferon- α therapy. Ann Intern Med 1995; 122: 254–261
   PubMed Web of Science ®Google Scholar
• Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330: 820–825
   PubMed Web of Science ®Google Scholar
• McGlave, P, Arthur, D, Haake, R, et al. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation. J Clin Oncol 1987; 5: 1033–1040
   PubMed Web of Science ®Google Scholar
• Thomas, ED, Clift, RA, Fefer, A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104: 155–155
   PubMed Web of Science ®Google Scholar
• Goldman, JM, Gale, RP, Horowitz, MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806–806
   PubMed Web of Science ®Google Scholar
• Devergie, A, Reiffers, J, Vernant, JP, et al. Long term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse. Bone Marrow Transplant 1990; 5: 379–379
   PubMed Web of Science ®Google Scholar
• Porter, DL, Roth, MS, McGarigle, C, et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100–106
   PubMed Web of Science ®Google Scholar
• Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710–1717
   PubMed Web of Science ®Google Scholar
• Kolb, HJ, Mittmuller, J, Clemm, C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462–2465
   PubMed Web of Science ®Google Scholar
• van Rhee, F, Lin, F, Cullis, JO, et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377–3383
   PubMed Web of Science ®Google Scholar
• Bar, BMAM, Schattenberg, A, Mensink, EJBM, et al. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993; 11: 513–519
   PubMed Web of Science ®Google Scholar
• Hertenstein, B, Wiesthneth, M, Novotny, J, et al. Interferon-α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 1993; 56: 1114–1118
   PubMed Web of Science ®Google Scholar
• Drobyski, WR, Keever, CR, Roth, MA, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310–2318
   PubMed Web of Science ®Google Scholar
• Kolb, HJ, Mittermuller, J, Hertenstein, H, et al. Adoptive immunotherapy in human and canine chimeras: the role of interferon alpha. Seminars in Hematology 1993; 30: 37–39
   PubMed Web of Science ®Google Scholar
• Drobyski, WR, Roth, MS, Thibodeau, SN, et al. Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1992; 10: 301–304
   PubMed Web of Science ®Google Scholar
• Mrsic, M, Horowitz, MM, Atkinson, K, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplantation 1992; 9: 269–275
   PubMed Web of Science ®Google Scholar
• Radich, JP, Gehly, G, Gooley, T, et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632–2638
   PubMed Web of Science ®Google Scholar
• Antin JH. Graft-versus-leukemia: no longer an epiphenomenon. Blood 1993; 82: 273–277
   Web of Science ®Google Scholar
• Kolb, HJ, Schattenberg, A, Goldman, JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions. Bone Marrow Transplantation 1995; 15: S2–S2, Abstract 34
   Web of Science ®Google Scholar
• Szer, J, Grigg, AP, Phillips, GL, et al. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT. Bone Marrow Transplantation 1993; 11: 109–111
   PubMed Web of Science ®Google Scholar
• Ferster, A, Bujan, W, Mouraux, T, et al. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplantation 1994; 14: 331–332
   PubMed Web of Science ®Google Scholar
• Mackinnon S. Adoptive immunotherapy using escalating doses of donor leukocytes for relapsed CML following allogeneic BMT. Bone Marrow Transplantation 1995; 15: S2–S2, Abstract 39
   Google Scholar
• Truitt, RL, LeFever, AV, Shih, CY, et al. Graft-vs-leukemia effect. Graft-vs-host disease: immunology, pathophysiology and treatment, SJ Burakoff, Deeg, HJ, Ferrara, J. Marcel Dekker, New York 1990; 177–204, In
   Google Scholar
• van Lochem E, de Gast B, Goulmy E. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplantation 1992; 10: 181–181
   PubMed Web of Science ®Google Scholar